V-Square Quantitative Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
V-Square Quantitative Management's ALNY Position: Q2 2026 in Review
V-Square Quantitative Management increased its Alnylam Pharmaceuticals (ALNY) stake by 12% in Q2 2026, buying an estimated $73K and bringing the position to 2,211 shares worth $666K. The position accounts for 0.06% of the portfolio, ranked #266.
V-Square Quantitative Management first reported a position in ALNY in Q2 2023 and has held it in 11 quarters since. The position peaked at $779K in Q4 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- V-Square Quantitative Management held 2,211 shares of Alnylam Pharmaceuticals worth $666K as of Q2 2026.
- V-Square Quantitative Management bought 242 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $73K.
- Alnylam Pharmaceuticals made up 0.06% of V-Square Quantitative Management's portfolio in Q2 2026, its #266 holding.
- V-Square Quantitative Management first reported a position in Alnylam Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
- V-Square Quantitative Management's Alnylam Pharmaceuticals position peaked at $779K in Q4 2025.
- 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.